Avalon (ALBT) GloboCare announced the renewal of the U.S. Food and Drug Administration, FDA, establishment registration for the KetoAir device by Qi Diagnostics Limited, a nanosensor-based diagnostic technologies company. Avalon markets and distributes the KetoAir device, a handheld breathalyzer designed for ketogenic health management which is registered with the U.S. Food and Drug Administration under registration number 3026284320
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALBT:
- Avalon GloboCare Regains Nasdaq Compliance, Strengthens Listing Status
- Avalon regains compliance with Nasdaq stockholders’ equity rule
- Avalon GloboCare Shareholders Elect Directors, Ratify Auditor
- Avalon GloboCare highlights RPM AI video platform integration
- Avalon GloboCare Acquires RPM Interactive for $19.5 Million
